Hengrui Pharma and Bristol-Myers Squibb Announce Global Strategic Collaboration on 13 Early-Stage Therapeutic Programs
May 12, 2026 12:11
CST Updated
May 19, 10:47
Hengrui Pharma
Innovative and High-Quality Pharmaceutical Developer